The Estee Lauder Companies Inc.
EL Consumer Defensive Household & Personal Products
The Estee Lauder Companies Inc.’s revenue for fiscal 2026 (year ended June 2026) was $15.0 billion, up 5.05% from fiscal 2025.
- Revenue
- +6.72%
- EPS
- +393.3%
- Free cash flow
- +46.1%
- Total debt
- −0.98%
Quarter to September 2026, against a year earlier
Follow EL
Alert me
The Estee Lauder Companies Inc. (EL) valuation and DCF model
At $108.45 the price implies free cash flow after share-based pay growing 13.2% a year for ten years.
Free cash flow after share-based pay grew −4.8% a year over the last ten years, −24.8% over the last five. The price asks for 18.0 points a year more than its ten-year rate. The industry’s median company is priced for 10.7%.
In June 2017 the price assumed 13.9% a year; The Estee Lauder Companies Inc. went on to grow free cash flow after share-based pay −0.7% a year to FY2026.
- The price needs
- 13.2% a year for ten years
- $108.45
- today’s price
- Its base case
- −4.8% a year for five years, then −2.9%
- $21.72
- 80.0% below today’s price
Base case on its own ten-year record The Estee Lauder Companies Inc.’s own growth, carried forward
Its assumptions
Powerpack lets you start from a scenario and type over any of them.
How we got there$6.44b 10 years of cash to equity+$5.55b terminal value−$4.05b net debt=$7.94b equity value÷365.28m shares=$21.72 per share
Valuation against its own history
| Multiple | Current | 5Y avg | 10Y avg | vs 10Y avg | Industry median | vs industry | 10Y range |
|---|---|---|---|---|---|---|---|
| P/E | 106.19× | 93.14× | 71.81× | 48% above | 25.45× | 317% above | |
| P/FCF | 25.80× | 42.68× | 40.34× | 36% below | 20.67× | 25% above | |
| P/B | 9.76× | 8.90× | 12.32× | 21% below | 2.43× | 301% above | |
| EV/EBITDA | 24.06× | 172.47× | 102.24× | 76% below | 13.40× | 80% above | |
| EV/Sales | 2.84× | 2.94× | 4.03× | 30% below | 1.24× | 129% above |
EL trades at 106.19× P/E, against a 10-year average of 71.81× (range 28.23×–154.80×). That is dearer than 89% of the last 9 year-end readings; re-rating to the average implies $73.34 per share.